Jonathan Ashley Jefferson

Jonathan Jefferson practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Jonathan Jefferson's NPI, 1710062526, was assigned on October 27, 2006. Jonathan Jefferson holds Washington license MD00041603.

Jonathan Jefferson's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Jonathan Jefferson's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Jonathan Jefferson to 1 more hospital, 1 dialysis center, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jonathan Jefferson practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Jonathan Jefferson's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Jonathan Jefferson is licensed in Washington.

CMS data shows 408 Medicare services from Jonathan Jefferson across 7 procedure codes in 2024, for 162 Medicare patients. Medicare paid $34,765 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 162 Medicare patients who saw Jonathan Jefferson in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 4.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jonathan Jefferson's median patient age at 50, with 50% women.

In 2024, Jonathan Jefferson wrote 812 Medicare Part D claims for 71 patients. 90% of them were for generic drugs. CMS names the drug for 615 of them, across 23 drugs with 11 or more claims each, at $350,654 in total drug cost. In 2023, CMS named 597 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Jonathan Jefferson for performance year 2024, reported through an alternative payment model (APM). Jonathan Jefferson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jonathan Jefferson as offering telehealth.

Dmand AI links 1 paper to Jonathan Jefferson in 2022. Jonathan Jefferson's most frequent co-authors are Nayan Arora, MD and Stuart J. Shankland.

CMS Open Payments shows 6 general payments to Jonathan Jefferson from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 99% of the total. Alexion Pharmaceuticals, Inc. paid the most, $248.